This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Next, pharma reps need to have a strong foundation in basic science and pharmacology. Pharmacology is the science of medications and the role they play in the body. Can you easily connect with others? If so, you might have the makings of a great pharmaceutical sales representative.
Regulation changes, like the introduction of the Prescription Drug Marketing Act in the 1980s, brought about a more structured approach. Whether it's adjusting to new market trends, shifting healthcare policies, or evolving customer needs, being able to pivot and adapt your approach is essential.
The growing issue of inequitable access is not just an issue of developing or emerging countries either; significant disparities in medicine availability exist within Europe where the time between regulatory approval (marketing authorisation) and true access for patients can vary from a few days to 2.5
Genentech, a subsidiary of Roche , markets alteplase and tenecteplase under the names Activase and TNKase in the US, while Boehringer sells them under the names Actilyse and Metalyse in the EU. But these substitutions do not come without complications, as these drugs can vary in their pharmacologic properties, states Page.
The global telemedicine market is projected to reach USD 396.76 The broader challenge in drug development is the staggering failure rate: of the compounds that begin as discovery projects, only about 10% make it to clinical trials, and of those, only 10% succeed in reaching the market. billion by 2027, growing at a CAGR of 25.8%.
We organize all of the trending information in your field so you don't have to. Join 8,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content